Stay updated on Sitravatinib Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Advanced NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check26 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check69 days agoChange DetectedThe webpage has updated the reporting dates for study results and clarified the definitions of key endpoints such as Objective Response Rate (ORR), Overall Survival (OS), and Progression Free Survival (PFS). Additionally, the number of participants experiencing adverse events is now included in the study's safety analysis.SummaryDifference8%
- Check76 days agoChange DetectedThe webpage has been updated to reflect a new version of the study, including the addition of collaborators and a principal investigator, while significant details about the study's design and objectives have been removed.SummaryDifference46%
- Check83 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Sitravatinib Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.